Larsen MJ, Thomassen M, Gerdes A-M, Kruse TA (2014) Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl) 8:145–155. https://doi.org/10.4137/BCBCR.S18715

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416. https://doi.org/10.1001/jama.2017.7112

Article  CAS  PubMed  Google Scholar 

van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J et al (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643–651. https://doi.org/10.1007/s10549-010-0805-3

Article  CAS  PubMed  Google Scholar 

Sessa C, Balmaña J, Bober SL, Cardoso MJ, Colombo N, Curigliano G et al (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline. Ann Oncol 34(1):33–47. https://doi.org/10.1016/j.annonc.2022.10.004

Article  CAS  PubMed  Google Scholar 

Carbine NE, Lostumbo L, Wallace J, Ko H (2018) Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev 4(4):CD002748. https://doi.org/10.1002/14651858.CD002748.pub4

Article  PubMed  Google Scholar 

Li X, You R, Wang X, Liu C, Xu Z, Zhou J et al (2016) Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res 22(15):3971–3981. https://doi.org/10.1158/1078-0432.CCR-15-1465

Article  CAS  PubMed  Google Scholar 

Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T et al (2021) Frequency of contralateral prophylactic mastectomy in breast cancer patients with a negative BRCA1 and BRCA2 rapid genetic test result. Ann Surg Oncol 28(9):4967–4973. https://doi.org/10.1245/s10434-021-09855-6

Article  PubMed  Google Scholar 

Armstrong J, Lynch K, Virgo KS, Schwartz MD, Friedman S, Dean M et al (2021) Utilization, timing, and outcomes of BRCA genetic testing among women with newly diagnosed breast cancer from a national commercially insured population: the ABOARD study. JCO Oncol Pract 17(2):e226–e235. https://doi.org/10.1200/OP.20.00571

Article  PubMed  PubMed Central  Google Scholar 

Heemskerk-Gerritsen BAM, Rookus MA, Aalfs CM, Ausems MGEM, Collée JM, Jansen L et al (2015) Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer 136(3):668–677. https://doi.org/10.1002/ijc.29032

Article  CAS  PubMed  Google Scholar 

Kruper L, Kauffmann RM, Smith DD, Nelson RA (2014) Survival analysis of contralateral prophylactic mastectomy: a question of selection bias. Ann Surg Oncol 21(11):3448–3456. https://doi.org/10.1245/s10434-014-3930-0

Article  PubMed  Google Scholar 

Rosenberg SM, Dominici LS, Gelber S, Poorvu PD, Ruddy KJ, Wong JS et al (2020) Association of breast cancer surgery with quality of life and psychosocial well-being in young breast cancer survivors. JAMA Surg 155(11):1035–1042. https://doi.org/10.1001/jamasurg.2020.3325

Article  PubMed  Google Scholar 

Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF et al (2022) Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction. JAMA Surg 157(6):e220631. https://doi.org/10.1001/jamasurg.2022.0631

Article  PubMed  PubMed Central  Google Scholar 

Luque Suarez S, Olivares Crespo ME, Brenes Sanchez JM, de la Herrera MM (2024) Immediate psychological implications of risk-reducing mastectomies in women with increased risk of breast cancer: a comparative study. Clin Breast Cancer 24(7):620–629. https://doi.org/10.1016/j.clbc.2024.07.005

Article  PubMed  Google Scholar 

Katz SJ, Kurian AW, Morrow M (2015) Treatment decision making and genetic testing for breast cancer: mainstreaming mutations. JAMA 314(10):997–998. https://doi.org/10.1001/jama.2015.8088

Article  CAS  PubMed  Google Scholar 

Grindedal EM, Jørgensen K, Olsson P, Gravdehaug B, Lurås H, Schlichting E et al (2020) Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway. Fam Cancer 19(2):133–142. https://doi.org/10.1007/s10689-020-00160-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E et al (2019) Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open 2(5):e194428. https://doi.org/10.1001/jamanetworkopen.2019.4428

Article  PubMed  PubMed Central  Google Scholar 

Bedrosian I, Somerfield MR, Achatz MI, Boughey JC, Curigliano G, Friedman S et al (2024) Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline. J Clin Oncol 42(5):584–604. https://doi.org/10.1200/JCO.23.02225

Article  PubMed  Google Scholar 

van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJT et al (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93(3):287–292. https://doi.org/10.1038/sj.bjc.6602703

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmidt MK, van den Broek AJ, Tollenaar RAEM, Smit VTHBM, Westenend PJ, Brinkhuis M et al (2017) Breast cancer survival of BRCA1/BRCA2 mutation carriers in a hospital-based cohort of young women. J Natl Cancer Inst 109(8):djw329. https://doi.org/10.1093/jnci/djw329

Article  CAS  Google Scholar 

Antunes Meireles P, Fragoso S, Duarte T, Santos S, Bexiga C, Nejo P et al (2023) Comparing prognosis for BRCA1, BRCA2, and non-BRCA breast cancer. Cancers (Basel) 15(23):5699. https://doi.org/10.3390/cancers15235699

Article  CAS  PubMed  Google Scholar 

Liu M, Xie F, Liu M, Zhang Y, Wang S (2021) Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 186(3):591–605. https://doi.org/10.1007/s10549-021-06104-y

Article  CAS  PubMed  Google Scholar 

Cronin-Fenton DP, Kjærsgaard A, Nørgaard M, Pedersen IS, Thomassen M, Kaye JA et al (2017) Clinical outcomes of female breast cancer according to BRCA mutation status. Cancer Epidemiol 49:128–137. https://doi.org/10.1016/j.canep.2017.05.016

Article  PubMed  Google Scholar 

Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D (2016) Effect of BRCA germline mutations on breast cancer prognosis: a systematic review and meta-analysis. Medicine 95(40):e4975. https://doi.org/10.1097/MD.0000000000004975

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurian AW, Ward KC, Abrahamse P, Bondarenko I, Hamilton AS, Deapen D et al (2021) Time trends in receipt of germline genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2012–2019. J Clin Oncol 39(15):1631–1640. https://doi.org/10.1200/JCO.20.02785

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans DG, Phillips K-A, Milne RL, Fruscio R, Cybulski C, Gronwald J et al (2021) Survival from breast cancer in women with a BRCA2 mutation by treatment. Br J Cancer 124(9):1524–1532. https://doi.org/10.1038/s41416-020-01164-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambertini M, Ceppi M, Hamy AS, Caron O, Poorvu PD, Carrasco E et al (2021) Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. NPJ Breast Cancer 7(1):16. https://doi.org/10.1038/s41523-021-00224-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurian AW, Abrahamse P, Bondarenko I, Hamilton AS, Deapen D, Gomez SL et al (2022) Association of genetic testing results with mortality among women with breast cancer or ovarian cancer. J Natl Cancer Inst 114(2):245–253. https://doi.org/10.1093/jnci/djab151

Article